As bombs fell on Tehran and missiles streaked across the Gulf, the stock portfolios of dozens of U.S. lawmakers climbed quietly upward. The men and women voting to fund the war also held shares in the companies supplying it. This is not a coincidence. It is a system.
Following the first U.S. strikes on Iran, as news anchors tallied the dead and generals briefed a shocked Senate, something else was happening on Wall Street. Defense stocks surged. Lockheed Martin rose 3.4%. RTX formerly Raytheon climbed 4.7%. Northrop Grumman added 6%. For investors holding those shares, it was a profitable morning. For the dozens of U.S. lawmakers who also held those shares, it was a profitable morning made possible, in part, by decisions they themselves had helped authorise.
The pattern that has emerged from a forensic review of congressional financial disclosures is not subtle. In the months leading up to the February 2026 strikes on Iran as classified briefings intensified, as military assets were moved into the region, as the diplomatic clock ran down members of Congress with direct oversight of foreign policy, intelligence and defense appropriations were buying shares in the companies that manufacture the weapons those policies deploy. No charges have been filed; no investigation has been formally opened. Under the current legal framework, what happened was entirely permitted. That is precisely the problem.
According to disclosures compiled by Capitol Trades and analyzed by Sludge, at least 19 members of the U.S. House and Senate reported purchases of stock in companies involved in the Iran strikes and other top-100 defense contractors since President Trump’s election victory in November 2024. The total estimated mid-range value of those disclosed purchases runs well into the millions of dollars across dozens of individual transactions.
The most striking case involves Senator Ashley Moody of Florida, who purchased shares in Howmet Aerospace a critical supplier of engine components and structural forgings used in military aircraft and missiles twice in early 2025. Her first position, purchased in January, has since appreciated by more than 107%. A second position bought in April is up more than 133%. Both purchases predated the February 2026 strikes, but the timing coincided with a period of rising U.S.-Iran tensions and escalating military deployments to the region.
Representative Michael McCaul of Texas, who chairs the House Foreign Affairs Committee and receives regular classified briefings on Iran and regional security, was also active. In January 2025 he made two purchases of GE Aerospace stock now up 76% and 82% respectively. In March, he added Woodward Inc., a manufacturer of precision controls and actuation systems used in military platforms, a position now up 114%. McCaul’s committee role places him among the first to know how close U.S.-Iran diplomacy is to collapse. His investment portfolio has appeared to reflect that proximity.
These are not isolated examples. A broader analysis of 2025 disclosures shows that RTX, Lockheed Martin, L3Harris, Northrop Grumman, and GE Aerospace were all purchased by multiple lawmakers in the months before the war, many of which have since returned 50 to 100 per cent gains. The S&P 500 Aerospace & Defense sub-index surged more than 150% between 2020 and 2025, leaving the sector at historically elevated valuations nearly 32 times forward earnings versus the broader market’s 20 times. Congress has been along for the ride.
The Stop Trading on Congressional Knowledge Act known as the STOCK Act was passed in 2012 with bipartisan fanfare. Its premise was simple: elected officials must publicly disclose any stock trade within 45 days of making it. The logic was that sunlight, in the famous formulation, would be the best disinfectant. Thirteen years later, ethics experts and reform advocates from both parties have concluded that the law has failed. Not partially. Comprehensively.
The enforcement mechanism at the heart of the STOCK Act is a fine of $200 for late or missing disclosures. For members of Congress making trades worth hundreds of thousands of dollars trades that in some cases have returned six-figure profits a $200 penalty functions not as a deterrent but as a minor administrative overhead, the cost of doing business without inconvenient scrutiny.
The structural advantage that makes congressional stock trading uniquely corrosive is not simply access to legislative schedules. It is access to classified information. Members sitting on the Senate Armed Services Committee, the House Intelligence Committee, and the Defense Appropriations subcommittee receive daily intelligence briefings on threat assessments, military readiness, and diplomatic negotiations that the investing public will not see for weeks, months, or sometimes years. Under current law, none of that gives rise to a legal prohibition on stock trading.
The result is a system in which a Senator who attends a closed-door briefing on the deterioration of U.S.-Iran nuclear talks as multiple members did in the weeks before the February 2026 strikes is free to purchase shares in Raytheon the same afternoon. Provided the trade is disclosed within 45 days and the Senator does not act on a specific, material, non-public fact about a named company’s contracts, the law permits it. The line between acting on geopolitical foreknowledge and acting on corporate insider information is one that critics argue has become, in practice, impossible to enforce.
Between 2020 and 2025, the top five U.S. defense contractors Lockheed Martin, RTX, Boeing, General Dynamics and Northrop Grumman received $771 billion in Pentagon contract awards, roughly one-third of the total $2.4 trillion in defense contracts awarded over that period. During the same five years, those same firms paid out more than $110 billion in dividends and stock buybacks to shareholders. The top 1 per cent of Americans control roughly half of all wealth invested in the stock market, meaning the returns from America’s wars are distributed with extraordinary concentration toward those who need them least.
In the current 119th Congress, at least 25 separate bills or resolutions have been introduced proposing to limit or prohibit congressional stock trading. The most comprehensive, the Ending Trading and Holdings in Congressional Stocks Act, known as the ETHICS Act has more than 80 co-sponsors and would prohibit lawmakers and their spouses from owning or trading individual stocks entirely. A Senate companion measure, the HONEST Act, was ordered to be reported by committee in July 2025. It has not reached a floor vote.
The ETHICS Act’s lead sponsor, Representative Raja Krishnamoorthi, has been direct about what the bill addresses: “When Members of Congress hold financial assets that stand to be affected by their own policy decisions, it creates not just the appearance, but often the reality, of a conflict of interest.” Polling by multiple organisations consistently finds that approximately 86% of Americans support banning congressional stock trading outright, a figure that holds across party identification. Yet the ban has never passed. It is proposed, it is lauded, it is referred to committee, and it dies.
The mechanism by which it dies is worth understanding. Reform bills attract co-sponsors from lawmakers who know they will never face a floor vote. Leadership in both chambers has shown little appetite to force one. The STOCK Act itself was passed precisely because it was weak enough to survive: it created the appearance of accountability without the substance, satisfying enough public pressure to forestall the more meaningful prohibition that reformers sought. That is a political template that has been replicated ever since.
As the Iran ceasefire now enters its fragile first hours, and as delegations prepare for Islamabad, a $200 billion war supplemental awaits Congressional approval in Washington. The companies that will receive the bulk of those contracts Lockheed Martin, RTX, Northrop Grumman, General Dynamics are the same companies whose shares sit in the portfolios of the lawmakers who will vote on the bill. This is not a conspiracy. It is something more troubling than that: a legal architecture that has been carefully constructed to ensure that the people who decide when wars begin, how long they last, and who supplies them are among the most financially motivated to see them continue.
Forty days of war have just ended in a fragile ceasefire. The men and women who voted for the authorizations, approved the supplements, and received the classified briefings will now vote on what comes next. Some of them will be richer for all of it. Under current American law, every cent of it was perfectly legal.
